Sage Bionetworks
@Sagebio
Followers
5K
Following
915
Media
162
Statuses
3K
Better Science Together | We are driving a new age of discovery through truly open science and radical collaboration.
Seattle WA USA
Joined April 2010
BIG NEWS: We have just launched SynapseChat! 🤖 We now have an AI chatbot integrated into our Synapse platform. This is the best example of an LLM built into an NIH-listed generalist repository. It’s going to transform the way researchers find and query data. So what does it
0
0
2
🧬 Help Advance Genomic Interpretation—Join a CAGI7 Challenge! Sage Bionetworks is excited to support the recently launched CAGI7 (Critical Assessment of Genome Interpretation) challenges—open to researchers, data scientists, and students who want to help predict the functional
0
2
3
As with others, we at Sage Bionetworks are mourning the passing of Atul, our colleague and joint architect of this organization. One instance that illustrates how important his voice was to Sage is the time when, along with Trey Ideker and Eric Schadt, Atul helped us form the
0
1
5
Registration is open for the TREAT-AD webinar April 29 at 1pm ET! Learn from Dr. Greg Cary of the @jacksonlab about the team's in vitro screening approach to identify promising targets for #Alzheimers disease. @EmoryMedicine @thesgconline @Sagebio
https://t.co/KVd7LwIiBv
0
1
1
Don't miss this webinar! Sign up now to attend Evaluation of Therapeutic Hypotheses & Targets Prioritized from Systems-level Analyses of #Alzheimers disease:
Registration is open for the TREAT-AD webinar April 29 at 1pm ET! Learn from Dr. Greg Cary of the @jacksonlab about the team's in vitro screening approach to identify promising targets for #Alzheimers disease. @EmoryMedicine @thesgconline @Sagebio
https://t.co/KVd7LwIiBv
0
2
0
Big News for Aging and Longevity Research! 🧬 We have now launched the ELITE portal (Exceptional Longevity Translational Resources)—the largest open-access molecular data repository dedicated to studying exceptional human longevity! 💡 Why ELITE matters: 🔹 Fosters
0
0
1
Collaboration is critical for advancing cancer research and transforming patient outcomes. For this to occur, we need rich, multi-modal datasets to be widely accessible to the scientific community. At Sage Bionetworks, we’re proud to be part of the HTAN Data Coordinating Center
0
1
1
We now have over 3.5 petabytes of biomedical data on our Synapse platform for the research world to reuse. And it's easier than ever to discover the datasets you're looking for and how they can accelerate your research. Introducing the Synapse Data Catalog!
0
0
1
Autoimmune diseases like rheumatoid arthritis and lupus affect millions, yet finding effective treatments remains a major challenge. This Autoimmune Awareness Month, we’re spotlighting our ARK portal—a game-changer for autoimmune research. ARK accelerates discoveries by making
arkportal.synapse.org
The ARK Portal hosts data generated by a network of research teams working collaboratively to deepen the understanding of Arthritis and Autoimmune and Related Diseases. It was established by the...
0
0
2
🚀 Join Us at Sage Bionetworks – Senior Scientific Program Manager Opportunity! 🚀 We’re looking for a Senior Scientific Program Manager to support groundbreaking Alzheimer’s disease research. This role will drive multi-institutional collaboration, oversee data coordination
0
0
2
It’s now easier than ever to discover, access, and cite high-quality datasets hosted on our Synapse platform. Synapse is being added to the Data Citation Index on Web of Science, which provides descriptive records for data objects and links them to the relevant literature
0
0
1
NOW LIVE: The AD Discovery Portal, a public facing catalog for enhanced data discovery! Designed to be open to all, the Portal allows anyone to find datasets available through AD Workbench without having to log in. Discover over 100 datasets here: https://t.co/ZoB3NwTcTL
0
4
6
BIG NEWS 🚀 We are delighted to announce that Andrea Varsavsky, PhD has joined Sage as our new Chief Operating Officer! Andrea will use her 20+ years of experience in healthcare technology, operations, and analytics to help us accelerate cutting-edge research and new pathways to
0
0
0
1/6 📢 For day 4 #LoveData25, we explore how @Sagebio advances open science through collaborative challenges! Check out our three flagship platforms that bring researchers together to solve complex biomedical problems 🧬🔬 #LoveData25 #CriticalAssesment #Challenges #Benchmarking
1
1
1
🧬 Excited to share the ARK Portal - a game-changing knowledge hub for autoimmune disease research! With 36TB+ of molecular data, we're building a unified platform to accelerate discoveries and improve patient outcomes. https://t.co/Smmirgr0sU
#LoveData25 #AutoimmuneResearch
arkportal.synapse.org
The ARK Portal hosts data generated by a network of research teams working collaboratively to deepen the understanding of Arthritis and Autoimmune and Related Diseases. It was established by the...
0
1
1
🧠Exploring #AlzheimersDisease research? Check out the AD Knowledge Portal & Agora - free, open-access resources with data from 41,000+ biospecimens! Perfect for researchers studying molecular mechanisms & therapeutic targets 🔬 #LoveData25 #OpenScience
adknowledgeportal.synapse.org
Discover and download Alzheimer's Disease data, analyses, and tools from the National Institute on Aging's Alzheimer's Disease Translational Research Program.
1
2
1
🔬✨ Reproducibility is the backbone of science—and Synapse is here to strengthen it. With Synapse, researchers can easily share data, code, and workflows in one place, ensuring that every step of their work is transparent and repeatable. 🧬 From version-controlled datasets to
0
0
1
The model for developing new diagnostics and treatments for those with ALS (amyotrophic lateral sclerosis) is about to undergo a major transformation. We’re helping to build the largest openly accessible data source for ALS research, enabling scientists to find and validate
fnih.org
The Accelerating Medicines Partnership® (AMP®) Amyotrophic Lateral Sclerosis (AMP ALS) is accelerating therapeutic and biomarker development for ALS by addressing the challenges of disease heteroge...
0
0
1
For some cancer patients, immunotherapy can be a life-saving medicine. But for others, it barely makes a difference? Why do people respond so uniquely to different interventions? That’s exactly what we’ve been trying to find out. We maintain the CRI iAtlas, an interactive
1
0
1
We’re partnering with @Sagebio to enable interoperability between the NIH-supported AD Knowledge Portal and AD Workbench. This collaboration will continue to foster data sharing and open science to advance Alzheimer’s research. Access available data here: https://t.co/E0d8byitvy
0
2
5
As a researcher, it can be hard choosing an open science platform that makes it easy to both deposit your own work AND find the latest research data from your peers. For users like Vilas Menon, Synapse is helping to advance completely new discoveries from a growing bank of
0
0
0